Refractory/Relapsed Classic Hodgkin Lymphoma Mimicking Disseminated Tuberculosis

<b>Background/Objectives:</b> Classic Hodgkin lymphoma (cHL) is a predominantly curable B-cell malignancy. However, primary refractory and relapsed (R/R) cHL remain therapeutic challenges, especially in regions with high tuberculosis (TB) prevalence, where clinical and radiologic feature...

Full description

Bibliographic Details
Published in:Hemato
Main Authors: Mohamed Nazem Alibrahim, Hussein Hammam, Antonino Carbone, Noor Alsaleh, Annunziata Gloghini
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Subjects:
relapsed/refractory cHL
Hodgkin disease
tuberculosis
immunotherapy
stem cell transplantation
Online Access:https://www.mdpi.com/2673-6357/6/2/12

Internet

https://www.mdpi.com/2673-6357/6/2/12

Similar Items